Melinta raises $30M in financing; ALK, bioCSL ink partnership;

@FierceBiotech: Buoyed by 6-week hep C data, Achillion sets out to test even faster cure. Report | Follow @FierceBiotech

@JohnCFierce: $RGLS slides after hep C contender's results underwhelm investors. $RGLS down 17%; mixed data for hep C at this stage? More | Follow @JohnCFierce

@DamianFierce: Impressed Achillion has been so successful considering its name sounds like a 6-year-old trying to think of a really big number. | Follow @DamianFierce

> Melinta Therapeutics says it has lined up $30 million in debt financing. Release

> ALK and bioCSL today announced that they have entered into a long-term partnership covering three ALK products in Australia and New Zealand. Release

Medical Device News

@FierceMedDev: Medtronic settles with DOJ over false Medicare claims for neurostimulation devices. More | Follow @FierceMedDev

@VarunSaxena2: ICYMI: Study: Intuitive's da Vinci surgical robot enables more minimally invasive surgeries in kidney cancer patients. Story | Follow @VarunSaxena2

@EmilyWFierce: Quest and Myriad Genetics end BRCA patent battle. Release | Follow @EmilyWFierce

> U.S. DOJ probes Olympus over kickbacks, false marketing claims. More

> Swedish asthma diagnostic company Aerocrine raises $53M after recent FDA nod. News

Pharma News

@FiercePharma: Merck hands over #China joint venture to partner Simcere Pharma. News  | Follow @FiercePharma

@CarlyHFierce: Daiichi's new clot-fighter Savaysa can't make up for $2.6B Benicar patent loss: analysts. More | Follow @CarlyHFierce

> FDA to pharma: Scrap that fine-print risk info in DTC ads. Story

> Drugmakers fall in line with Pakistani government's price-cutting plans. Article

> Roche boasts new Lucentis approval for retinal damage in diabetes. News

Biotech IT News

> FDA seeks budget boost for precision medicine IT infrastructure. More

> Apple edges ahead of Google in race to become a health data repository. Report

> Medidata posts 50% jump in partial SDV clients as risk-based monitoring takes off. Story

> TrialReach raises $13.5M for clinical trial-patient matching service. Item

> Merck joins Novartis, Pfizer on tech-enabled protein consortium with $6M buy in. Article

CRO News

> Quintiles' founder heads for the exit after 30-plus years as chairman. News

> BioClinica touts a big year for its eClinical biz. More

> TrialReach raises $13.5M to connect patients with studies. Story

> Icon buys a market-access firm for $120M. Article

> Covance ticks up revenue on the eve of a merger. Report

Animal Health News

> Ahead of AmerisourceBergen merger, MWI charts double-digit sales growth. Item

> New pet-care apps arm owners, veterinarians with mobile diagnostic tools. More

> Nexvet Biopharma sees sluggish market reception following IPO. Report

> Pet tear-stain removers still widely available despite FDA warnings. Story

> Pet owners jump on antivaccine bandwagon, ignoring veterinarians' advice. Article

Suggested Articles

When it’s time to go public, most biotech companies for the Nasdaq. Not so for SQZ Biotech, which raised $71 million in its NYSE debut.

The saga of COVID antibody R&D continues as the REGN-COV2 antibody cocktail used by President Donald Trump has been hit by safety concerns.

A Dartmouth-led team proposed a method for targeting and inhibiting the most aggressive cells in breast tumors to improve responses to chemotherapy.